Prime Highlights-
- UK life sciences sector draws over £3 billion in investment to boost innovation and patient care nationwide.
- Investment push aims to create 66,000 new sector jobs and position UK as a top three life sciences economy by 2035.
Key Facts-
- AstraZeneca commits £300 million to Cambridge and Macclesfield drug discovery operations.
- Clinical trial setup times drop from 169 to 122 days across the sector.
Background-
The UK life sciences sector pulled in over £3 billion in new investment across public and private sources during the past year, reinforcing efforts to cement the country’s standing as a global science and health leader. The funding announcement came ahead of Andy Burnham taking charge as prime minister.
The investment promises patients nationwide faster access to new treatments, including the world’s first immunotherapy for Type 1 diabetes. It also supports government ambitions to create 66,000 additional roles in the sector by 2035.
Clinical trial setup times have already improved, dropping from 169 days to 122 days in the first half of the 2025-26 period, easing pressure on an NHS system facing significant waiting lists.
Patients can also expect to access new medicines up to six months sooner under a joint approval process between the Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence.
Private companies have driven much of the investment surge. AstraZeneca has committed £300 million to expand operations in Cambridge and Macclesfield, using artificial intelligence to accelerate drug discovery.
Moderna has opened an innovation centre in Oxfordshire, backed by a £1 billion UK research and development commitment spanning the next decade.
The government recently updated its Life Sciences Sector Plan, outlining ambitions for the UK to become the world’s third largest life sciences economy by 2035.
Then-science, innovation and technology secretary Liz Kendall said the plan delivered cutting-edge cancer treatments, fresh opportunities for British businesses to grow, and well-paid jobs that improve family livelihoods in its first year.
The sector currently generates around £147 billion in turnover and employs 360,000 people, with nearly half based outside London, the East and South East of England.
